These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


149 related items for PubMed ID: 30240283

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In silico prediction of acyl glucuronide reactivity.
    Potter T, Lewis R, Luker T, Bonnert R, Bernstein MA, Birkinshaw TN, Thom S, Wenlock M, Paine S.
    J Comput Aided Mol Des; 2011 Nov; 25(11):997-1005. PubMed ID: 22042375
    [Abstract] [Full Text] [Related]

  • 4. Determination of degradation pathways and kinetics of acyl glucuronides by NMR spectroscopy.
    Walker GS, Atherton J, Bauman J, Kohl C, Lam W, Reily M, Lou Z, Mutlib A.
    Chem Res Toxicol; 2007 Jun; 20(6):876-86. PubMed ID: 17536843
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differentiation of Deprotonated Acyl-, N-, and O-Glucuronide Drug Metabolites by Using Tandem Mass Spectrometry Based on Gas-Phase Ion-Molecule Reactions Followed by Collision-Activated Dissociation.
    Niyonsaba E, Easton MW, Feng E, Yu Z, Zhang Z, Sheng H, Kong J, Easterling LF, Milton J, Chobanian HR, Deprez NR, Cancilla MT, Kilaz G, Kenttämaa HI.
    Anal Chem; 2019 Sep 03; 91(17):11388-11396. PubMed ID: 31381321
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. NMR and QSAR studies on the transacylation reactivity of model 1beta-O-acyl glucuronides. I: design, synthesis and degradation rate measurement.
    Vanderhoeven SJ, Lindon JC, Troke J, Tranter GE, Wilson ID, Nicholson JK.
    Xenobiotica; 2004 Jan 03; 34(1):73-85. PubMed ID: 15729774
    [Abstract] [Full Text] [Related]

  • 9. Toxicological potential of acyl glucuronides and its assessment.
    Iwamura A, Nakajima M, Oda S, Yokoi T.
    Drug Metab Pharmacokinet; 2017 Feb 03; 32(1):2-11. PubMed ID: 28017536
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Kinetic modelling of acyl glucuronide and glucoside reactivity and development of structure-property relationships.
    Bradshaw PR, Richards SE, Wilson ID, Stachulski AV, Lindon JC, Athersuch TJ.
    Org Biomol Chem; 2020 Feb 19; 18(7):1389-1401. PubMed ID: 32002533
    [Abstract] [Full Text] [Related]

  • 16. Rapid internal acyl migration and protein binding of synthetic probenecid glucuronides.
    Akira K, Uchijima T, Hashimoto T.
    Chem Res Toxicol; 2002 Jun 19; 15(6):765-72. PubMed ID: 12067243
    [Abstract] [Full Text] [Related]

  • 17. Synthesis, transacylation kinetics and computational chemistry of a set of arylacetic acid 1beta-O-acyl glucuronides.
    Berry NG, Iddon L, Iqbal M, Meng X, Jayapal P, Johnson CH, Nicholson JK, Lindon JC, Harding JR, Wilson ID, Stachulski AV.
    Org Biomol Chem; 2009 Jun 21; 7(12):2525-33. PubMed ID: 19503925
    [Abstract] [Full Text] [Related]

  • 18. Chemistry and reactivity of acyl glucuronides.
    Stachulski AV.
    Curr Drug Metab; 2011 Mar 21; 12(3):215-21. PubMed ID: 20946098
    [Abstract] [Full Text] [Related]

  • 19. Predicting the pharmacokinetics of acyl glucuronides and their parent compounds in disease states.
    Liu JH, Smith PC.
    Curr Drug Metab; 2006 Feb 21; 7(2):147-63. PubMed ID: 16472105
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.